Retatrutide acts as a triple agonist targeting GIP, GLP-1, and glucagon receptors, producing weight loss averaging 24.2% in clinical trials
If youre considering switching or exploring these options further, dont hesitate to sign up for personalized guidance from our Healthon clinicians, who can help guide you through your weight management and medication options
While most bruising is simple and harmless, knowing when to speak to a doctor can make a big difference in staying safe and healthy
It can also lead to underdosing, which can hinder your progress and slow down your weight loss journey
The brand source materials state that altRx-affiliated medical professional entities are not contracted healthcare providers with any health insurance plans, including commercial plans and government programs like Medicaid and Medicare
While evidence on how this therapy may interact with weight-loss medications is limited, some research has shown that postmenopausal women using hormone therapy experience greater weight loss when treated with the GLP-1-based obesity medication semaglutide
